Avandia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
Condition: Type 2 Diabetes MellitusInterventions: Drug: sitagliptin; Drug: Comparator: Placebo; Drug: rosiglitazone; Drug: metformin; Drug: glipizideSponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2006 Category: Research Source Type: clinical trials

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's DiseaseInterventions: Drug: Rosiglitazone Extended Release 2mg; Drug: Rosiglitazone Extended Release 8mg; Other: Placebo; Other: DonepezilSponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2006 Category: Research Source Type: clinical trials

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's DiseaseInterventions: Drug: Rosiglitazone Extended Release 2mg; Drug: Rosiglitazone Extended Release 8mg; Other: PlaceboSponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified May 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2006 Category: Research Source Type: clinical trials